Related references
Note: Only part of the references are listed.Selective targeting of antiapoptotic BCL-2 proteins in cancer
Ahmet Can Timucin et al.
MEDICINAL RESEARCH REVIEWS (2019)
Venetoclax: A new wave in hematooncology
Jana Mihalyova et al.
EXPERIMENTAL HEMATOLOGY (2018)
Novel phosphorylated TAK1 species with functional impact on NF-κB and β-catenin signaling in human Cutaneous T-cell lymphoma
Fernando Gallardo et al.
LEUKEMIA (2018)
Sezary syndrome-clinical and histopathologic features, differential diagnosis, and treatment
Kerith E. Spicknall
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2018)
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
Youn H. Kim et al.
LANCET ONCOLOGY (2018)
A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia
Haley E. Ramsey et al.
CANCER DISCOVERY (2018)
Malignant inflammation in cutaneous TaEurocell lymphoma-a hostile takeover
Thorbjorn Krejsgaard et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Matthew S. Davids et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
H. Miles Prince et al.
LANCET (2017)
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
John F. Seymour et al.
LANCET ONCOLOGY (2017)
NRAS mutations in cutaneous T cell lymphoma (CTCL) sensitize tumors towards treatment with the multikinase inhibitor Sorafenib
Michael K. Kiessling et al.
ONCOTARGET (2017)
Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sezary syndrome vs. HTLV-1+ leukemic cell lines
Elena Netchiporouk et al.
ONCOTARGET (2017)
Targeting Thioredoxin-1 by dimethyl fumarate induces ripoptosome-mediated cell death
Anne Schroeder et al.
SCIENTIFIC REPORTS (2017)
The elevated activation of NFκB and AP-1 is correlated with differential regulation of Bcl-2 and associated with oral squamous cell carcinoma progression and resistance
Manzar Alam et al.
CLINICAL ORAL INVESTIGATIONS (2017)
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma
Shaji Kumar et al.
BLOOD (2017)
Synergy of BCL2 and histone deacetylase inhibition against leukemic cells from cutaneous T-cell lymphoma patients
Benoit M. Cyrenne et al.
BLOOD (2017)
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting F-κB
Jan P. Nicolay et al.
BLOOD (2016)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Combination of retinoid and histone deacetylase inhibitor produced an anti-tumor effect in cutaneous T-cell lymphoma by restoring tumor suppressor gene, retinoic acid receptorβ2, via histone acetylation
Yukihiko Kato et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2016)
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
Andrew W. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma
Madeleine Duvic et al.
BLOOD (2015)
Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides
Laura Y. McGirt et al.
BLOOD (2015)
The BCL-2 protein family, BH3-mimetics and cancer therapy
A. R. D. Delbridge et al.
CELL DEATH AND DIFFERENTIATION (2015)
Bortezomib Inhibits Expression of TGF-β1, IL-10, and CXCR4, Resulting in Decreased Survival and Migration of Cutaneous T Cell Lymphoma Cells
Tzu-Pei Chang et al.
JOURNAL OF IMMUNOLOGY (2015)
Genomic landscape of cutaneous T cell lymphoma
Jaehyuk Choi et al.
NATURE GENETICS (2015)
The mutational landscape of cutaneous T cell lymphoma and Sezary syndrome
Ana Carolina da Silva Almeida et al.
NATURE GENETICS (2015)
Brentuximab as a Treatment for CD30+ Mycosis Fungoides and Sezary Syndrome
Tarun Mehra et al.
JAMA DERMATOLOGY (2015)
TNF-α mediates mitochondrial uncoupling and enhances ROS-dependent cell migration via NF-κB activation in liver cells
L. Kastl et al.
FEBS LETTERS (2014)
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome) Part II. Prognosis, management, and future directions
Sarah I. Jawed et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Peter E. Czabotar et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Lessons learned from gene expression profiling of cutaneous T-cell lymphoma
B. O. Dulmage et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
ABT-199: Taking Dead Aim at BCL-2
Matthew S. Davids et al.
CANCER CELL (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
A novel mouse model for Sezary Syndrome using xenotransplantation of Sezary cells into immunodeficient RAG2-/-γc-/- mice
Leslie van der Fits et al.
EXPERIMENTAL DERMATOLOGY (2012)
A PP4 Holoenzyme Balances Physiological and Oncogenic Nuclear Factor-Kappa B Signaling in T Lymphocytes
Markus Brechmann et al.
IMMUNITY (2012)
Sezary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)
Elise A. Olsen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Bortezomib Induces Nuclear Translocation of IκBα Resulting in Gene-Specific Suppression of NF-κB-Dependent Transcription and Induction of Apoptosis in CTCL
Ashish Juvekar et al.
MOLECULAR CANCER RESEARCH (2011)
Down-regulation of Bcl-2 is mediated by NF-κB activation in Helicobacter pylori-induced apoptosis of gastric epithelial cells
Sang Hui Chu et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Mitochondrial Reactive Oxygen Species Control T Cell Activation by Regulating IL-2 and IL-4 Expression: Mechanism of Ciprofloxacin-Mediated Immunosuppression
Marcin M. Kaminski et al.
JOURNAL OF IMMUNOLOGY (2010)
Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism
Jianguang Chen et al.
BLOOD (2009)
Inhibition of Constitutively Activated Nuclear Factor-κB Induces Reactive Oxygen Species- and Iron-Dependent Cell Death in Cutaneous T-Cell Lymphoma
Michael K. Kiessling et al.
CANCER RESEARCH (2009)
Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCγ1- and Ca2+-dependent apoptosis
Sven Baumann et al.
BLOOD (2008)
Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma
Christina M. Annunziata et al.
CANCER CELL (2007)
Novel role for mitochondria:: Protein kinase Cθ-dependent oxidative signaling organelles in activation-induced T-cell death
Marcin Kaminski et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak
Simon N. Willis et al.
SCIENCE (2007)
Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas
An Tae Jung et al.
ANNALS OF HEMATOLOGY (2006)
Down-regulating constitutive activation of the NF-κB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis
A Sors et al.
BLOOD (2006)
Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas
X Ni et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function
L Chen et al.
MOLECULAR CELL (2005)
Apoptotic resistance to ionizing radiation in pediatric B-precursor acute lymphoblastic leukemia frequently involves increased NF-κB survival pathway signaling
VJ Weston et al.
BLOOD (2004)
BH3 domains: intracellular death-ligands critical for initiating apoptosis
T Chittenden
CANCER CELL (2002)
Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells
RE Davis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Antioxidant activities of astaxanthin and related carotenoids
YMA Naguib
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2000)
Share Paper
